Welcome to our dedicated page for Universal Ins Hldgs SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Universal Insurance Holdings, Inc. filings document formal disclosures for a property and casualty insurance holding company that writes personal residential homeowners insurance and performs related risk management, claims management and distribution services. Recent Form 8-K reports furnish quarterly and annual results, non-GAAP reconciliations, premium measures, book value, dividends and share repurchase authorization announcements.
The company's proxy materials cover annual meeting matters, director elections, executive compensation advisory votes and independent auditor ratification. Regulatory filings also record Regulation FD disclosures, exhibit press releases and Inline XBRL cover-page data associated with capital return announcements and operating results.
Universal Insurance Holdings director reports a small insider sale. A director of Universal Insurance Holdings, Inc. (UVE) reported selling 1,855 shares of common stock on 12/30/2025 at a price of $33.61 per share. The transaction was coded as a sale and was carried out indirectly through The RDP Revocable Trust dated August 11, 2011, of which the director is the grantor and sole trustee and whose beneficiaries are the director's children. Following this sale, the director beneficially owns 8,319 shares indirectly through the trust and 19,136 shares directly.
Universal Insurance Holdings, Inc. CEO and director Stephen Donaghy reported open-market sales of company stock. On 12/29/2025, he sold 25,000 shares of common stock at a weighted average price of $34.07 per share, leaving him with 679,961 shares beneficially owned. On 12/30/2025, he sold an additional 25,000 shares at a weighted average price of $33.77 per share, after which he held 654,961 shares directly. The prices reflect multiple trades within narrow ranges on each day, and the reporting person has committed to provide full trade-by-trade detail upon request.
Universal Insurance Holdings, Inc. insider Sean P. Downes, a director and Executive Chairman, reported gifts of company common stock on 12/30/2025. The transactions were coded as gifts at a reported price of $0 per share.
Following these transactions, he directly beneficially owned 1,198,512 shares of common stock. He also reported indirect ownership of 48,000 shares held by his children and 2,000 shares held by his spouse.
An affiliate of UVE has filed a notice under Rule 144 to potentially sell up to 1,855 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 12/30/2025. The planned sale has an indicated aggregate market value of 63,330.
The shares to be sold were acquired on 12/09/2019 via a stock option exercise from the issuer, paid in cash on the same date. The table also reports that 28,048,881 shares of this class were outstanding; this is a baseline figure, not the amount being sold. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
A holder of UVE common stock filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16. The filing notes that 28,048,881 shares of the same class were outstanding. It also reports that the Stephen Donaghy Trust previously sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of $851,779.94. The seller represents that they do not know of any material adverse, non‑public information about the issuer’s current or prospective operations.
A shareholder identified as the Stephen Donaghy Trust has filed a Form 144 notice relating to common shares of UVE. The filing covers an intended sale of 25,000 common shares through Wells Fargo Clearing Services on the NYSE around 12/30/2025, with an aggregate market value of 844,398.16. These 25,000 shares were originally acquired on 11/15/2018 via an open market purchase paid in cash. The notice also reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of 851,779.94. By signing, the seller represents that they are not aware of any undisclosed material adverse information about UVE’s operations.
A shareholder of UVE has filed a notice of proposed sale of 25,000 shares of common stock under Rule 144. The shares are expected to be sold on the NYSE through Wells Fargo Clearing Services, with an indicated aggregate market value of $851,779.94. The filing notes that 28,048,881 shares of this class were outstanding.
The securities to be sold were originally acquired on 11/15/2018 in an open market purchase paid in cash. By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Universal Insurance Holdings disclosed equity transactions by its Principal Accounting Officer, reported as a single filer. The officer received and exercised restricted stock units (RSUs) that convert into shares of common stock, and had shares withheld to cover taxes.
On December 20, 2024, the officer was granted 4,000 RSUs, each representing one share of common stock, vesting in three approximately equal installments on each of the first three anniversaries of the grant date, subject to continued employment. On December 19, 2025, 1,667 RSUs were exercised at an exercise price of $0, and 406 shares of common stock were withheld at $33.89 per share to satisfy tax obligations. On December 20, 2025, 1,334 RSUs were exercised at $0, with 325 shares withheld at $34.63 per share for taxes.
After these transactions, the officer directly owned 7,312 shares of common stock and held remaining RSU awards as reported in the derivative securities table.
Universal Insurance Holdings, Inc. Executive Chairman and Director Sean P. Downes reported selling 20,000 shares of common stock on 12/19/2025 at a weighted average price of $33.8158 per share. The shares were sold in multiple transactions at prices ranging from $33.46 to $34.43.
After this sale, Downes beneficially owns 1,243,512 shares directly, plus 2,000 shares held indirectly by his spouse and 18,000 shares held indirectly by his children.
UVE filed a notice of proposed insider share sales under Rule 144. The filing covers a planned sale of 20,000 shares of common stock through Raymond James & Associates on the NYSE, with an aggregate market value of $680,000. The filing notes that 28,048,000 shares of common stock were outstanding at the time of the notice.
The 20,000 shares to be sold were originally acquired from the issuer on 03/13/2014 as compensation in lieu of cash, with payment also dated 03/13/2014 and described as cash. Over the past three months, the same seller disposed of 20,000 shares of common stock on 10/29/2025 for gross proceeds of $627,062.05 and another 20,000 shares on 11/25/2025 for gross proceeds of $668,114.05.